CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP)

Clinical trials for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) explained in plain language.

Never miss a new study

Get alerted when new CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) trials appear

Sign up with your email to follow new studies for CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 5 Not yet recruiting 5 Completed 1

Breakthrough: 88% of patients with severe asthma and nasal polyps achieve dual remission on dupilumab

Disease control Completed

This study looked at 28 adults with both severe asthma and chronic sinusitis with nasal polyps who were treated with dupilumab for 24 months. The goal was to see if the drug could help control both conditions at the same time, called 'dual remission.' After two years, 88% of pati…

Matched conditions: CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP)

Sponsor: Azienda Ulss 2 Marca Trevigiana • Aim: Disease control

Last updated May 14, 2026 12:05 UTC

CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP)

Get alerted when new CHRONIC RHINOSINUSITIS WITH NASAL POLYPS (CRSWNP) trials appear

Breakthrough: 88% of patients with severe asthma and nasal polyps achieve dual remission on dupilumab